Home » GSK Completes Trials for Combination Lung Drug
GSK Completes Trials for Combination Lung Drug
GlaxoSmithKline has completed final stage testing of its experimental once-daily lung disease drug LAMA/LABA and will press ahead with plans to file for approval of the medicine in global markets from the end of 2012.
Reuters
Reuters
Upcoming Events
-
07May
-
14May
-
30May